These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2984864)

  • 1. The chemical synthesis and antiviral properties of an acyclovir-phospholipid conjugate.
    Welch CJ; Larsson A; Ericson AC; Oberg B; Datema R; Chattopadhyaya J
    Acta Chem Scand B; 1985; 39(1):47-54. PubMed ID: 2984864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiviral activity of various esters of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine.
    Martin JC; Tippie MA; McGee DP; Verheyden JP
    J Pharm Sci; 1987 Feb; 76(2):180-4. PubMed ID: 3033195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effect of chinonin against herpes simplex virus.
    Jiang J; Li S; Li M; Xiang J
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(5):521-4. PubMed ID: 15641710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famciclovir/penciclovir.
    Sacks SL; Wilson B
    Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
    [No Abstract]   [Full Text] [Related]  

  • 6. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
    Park NH; Pavan-Langston D; McLean SL; Lass JH
    Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo antiviral activity of 2'-fluorinated arabinosides of 5-(2-haloalkyl)uracil.
    Rosenwirth B; Streicher W; De Clercq E; Wanek E; Schwarz W; Griengl H
    Antiviral Res; 1987 Jun; 7(5):271-87. PubMed ID: 2821896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of pyrophosphate analogues on cutaneous herpes simplex virus type 1 infection in guinea pigs.
    Wutzler P; Helbig B; Ulbricht A; Meerbach A; Pradel W
    Antiviral Res; 1988 Nov; 10(1-3):99-106. PubMed ID: 2852923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.
    Bacon TH; Levin MJ; Leary JJ; Sarisky RT; Sutton D
    Clin Microbiol Rev; 2003 Jan; 16(1):114-28. PubMed ID: 12525428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides.
    Smee DF; Campbell NL; Matthews TR
    Antiviral Res; 1985 Oct; 5(5):259-67. PubMed ID: 2998275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiviral activity of 3-substituted derivatives of 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purines, tricyclic analogues of acyclovir and ganciclovir.
    Boryski J; Golankiewicz B; De Clercq E
    J Med Chem; 1991 Aug; 34(8):2380-3. PubMed ID: 1652016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.
    Poryo A; Wigand R
    Med Microbiol Immunol; 1984; 173(4):219-24. PubMed ID: 6096685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 15. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of therapeutic drug monitoring in the long-term valaciclovir therapy of relapsing herpes simplex virus encephalitis in children.
    Lim M; Menson E; Tong CY; Lin JP
    J Antimicrob Chemother; 2009 Dec; 64(6):1340-1. PubMed ID: 19828489
    [No Abstract]   [Full Text] [Related]  

  • 17. Herpes simplex virus latency and nucleoside analogues.
    Efstathiou S; Field HJ; Griffiths PD; Kern ER; Sacks SL; Sawtell NM; Stanberry LR
    Antiviral Res; 1999 Apr; 41(3):85-100. PubMed ID: 10320042
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and antiviral activity of novel N-substituted derivatives of acyclovir.
    Boryski J; Golankiewicz B; De Clercq E
    J Med Chem; 1988 Jul; 31(7):1351-5. PubMed ID: 2455050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anti-HSV therapeutics target the helicase-primase complex.
    Crumpacker CS; Schaffer PA
    Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.